STOCK TITAN

PAVMED (PAVM) holder group reports 709,069 shares, 9.99% stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

PAVMED INC. holders report beneficial ownership totaling 709,069 shares (9.99%). The filing states the 709,069 shares include 49 shares, 500,000 Restricted Common Stock and 209,020 shares issuable upon exercise of warrants and conversion of notes. Percentages use 6,383,089 shares outstanding as of March 27, 2026. Holdings are reported as of March 31, 2026 and the issuable shares are subject to a 9.99% beneficial ownership blocker.

Positive

  • None.

Negative

  • None.

Insights

Large holder reports a near-10% position with derivative exposure.

The filing shows 709,069 shares attributed to the Reporting Persons, comprised of 49 issued shares, 500,000 restricted shares, and 209,020 issuable shares from warrants and notes. The percentage is calculated using 6,383,089 shares outstanding as of March 27, 2026.

Timing and conversion mechanics determine potential future voting or sale activity; the excerpt notes a 9.99% beneficial ownership blocker on the issuable shares, and further disclosures would specify conversion triggers and exercise rights.

Reporting structure ties a Cayman fund, a U.S. manager, and its managing member.

The filing explains the Fund holds the shares, Ayrton Capital LLC is Investment Manager, and Waqas Khatri is managing member; all three are named Reporting Persons with identical share counts. Sole voting and dispositive power are reported at 709,069 shares for each Reporting Person.

These attributions affect disclosure and control analysis; future Form 4s or amendments would clarify any changes in voting/disposition or exercises that alter ownership percentages.

Beneficial ownership 709,069 shares Total reported holdings as of March 31, 2026
Percent of class 9.99% Calculated using 6,383,089 shares outstanding as of March 27, 2026
Restricted Common Stock 500,000 shares Restricted shares held by the Reporting Persons
Issuable on exercise/conversion 209,020 shares Shares issuable upon exercise of Warrants and conversion of Notes
Shares outstanding 6,383,089 shares Shares outstanding used for percentage calculation as of March 27, 2026
Issued shares reported 49 shares Issued common shares held by the Reporting Persons
Restricted Common Stock financial
"500,000 shares of Restricted Common Stock held by the Reporting Persons"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
Warrants financial
"209,020 shares of Common Stock issuable on the exercise of certain warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
beneficial ownership blocker regulatory
"issuable shares of Common Stock related to the exercise of the Warrants ... are both subject to a 9.99% beneficial ownership blocker"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
Schedule 13G/A regulatory
"Item 1. Name of issuer: PAVMED INC. ... (Amendment No. 1 )"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Ayrton Capital report in PAVM?

Ayrton Capital reports beneficial ownership of 709,069 shares, representing 9.99% of the class using 6,383,089 shares outstanding as of March 27, 2026. The total includes restricted shares and issuable shares from warrants and notes.

How is the 709,069-share total composed for PAVM?

The 709,069 total comprises 49 issued shares, 500,000 Restricted Common Stock, and 209,020 shares issuable upon exercise of warrants and conversion of convertible notes, as reported in the filing.

What is the meaning of the 9.99% beneficial ownership blocker in this filing?

The filing states the shares issuable from the Warrants and Notes are subject to a 9.99% beneficial ownership blocker, which limits constructive ownership calculations at that threshold per the disclosed terms in the filing.

Which entities and individuals are the Reporting Persons in this Schedule 13G/A?

The Reporting Persons are Ayrton Capital LLC, Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (the Fund), and Waqas Khatri, who serves as managing member of the Investment Manager, per the filing.

What outstanding share count did the filing use to calculate percentages?

Percentages are based on 6,383,089 shares of Common Stock outstanding as of March 27, 2026, a figure cited in the issuer's 10-K and used in this Schedule 13G/A to compute the 9.99% holdings.





70387R502

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ayrton Capital LLC
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri / Managing Member
Date:05/11/2026
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri / Director
Date:05/11/2026
Waqas Khatri
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri
Date:05/11/2026